Literature DB >> 29353377

Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.

Ali Mohammadi Bardbari1, Mohammad Reza Arabestani1, Manoochehr Karami2, Fariba Keramat3,4, Hossein Aghazadeh5, Mohammad Yousef Alikhani6,7, Kamran Pooshang Bagheri8.   

Abstract

The rapid increase of drug resistance and failure of available antibiotics to treat biofilm-associated infections is of great health concern. Accordingly, our study aimed to evaluate the synergistic antibacterial, biofilm inhibitory, and biofilm removal activities of melittin in combination with colistin, imipenem, and ciprofloxacin against multidrug-resistant (MDR) strong biofilm producer Acinetobacter baumannii isolates. The kinetics of biofilm formation were evaluated for the isolates for 144 h. Minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), minimum biofilm inhibitory concentrations (MBICs), and biofilm removal activities for melittin and combinations with antibiotics were determined. Inhibition of biofilm-associated protein (bap) expression by melittin was evaluated with real-time polymerase chain reaction (PCR). Field emission scanning electron microscopy (FE-SEM) was used to visualize the effect of synergism on the inhibition of biofilm production. The geometric means of the fractional inhibitory concentration index (FICi) for melittin-colistin, melittin-imipenem, and melittin-ciprofloxacin combinations were calculated as 0.31, 0.24, and 0.94, respectively. Comparing the geometric means of the removal activity for melittin, colistin, imipenem, and combinations of them in both 6 and 24 h showed a significant difference between the groups (p-value < 0.05). Exposure to melittin induced a statistically significant downregulation of bap mRNA levels in all isolates at sub-MIC doses. Analysis of the FE-SEM results demonstrated that the synergism of melittin-colistin at 0.125-0.25 μg inhibited biofilm formation completely. In conclusion, our findings indicate that melittin possesses considerable potential for use in combination with colistin and imipenem to treat infections caused by MDR strong biofilm producer A. baumannii isolates.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29353377     DOI: 10.1007/s10096-018-3189-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  33 in total

Review 1.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

Review 2.  Antimicrobial peptides: general overview and clinical implications in human health and disease.

Authors:  Eduardo Guaní-Guerra; Teresa Santos-Mendoza; Saúl O Lugo-Reyes; Luis M Terán
Journal:  Clin Immunol       Date:  2010-01-29       Impact factor: 3.969

3.  Melittin induced cytogenetic damage, oxidative stress and changes in gene expression in human peripheral blood lymphocytes.

Authors:  Goran Gajski; Ana-Marija Domijan; Bojana Žegura; Alja Štern; Marko Gerić; Ivana Novak Jovanović; Ivana Vrhovac; Josip Madunić; Davorka Breljak; Metka Filipič; Vera Garaj-Vrhovac
Journal:  Toxicon       Date:  2015-12-15       Impact factor: 3.033

4.  In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.

Authors:  X Vila-Farres; C Garcia de la Maria; R López-Rojas; J Pachón; E Giralt; J Vila
Journal:  Clin Microbiol Infect       Date:  2011-06-14       Impact factor: 8.067

5.  A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms.

Authors:  Fany Reffuveille; César de la Fuente-Núñez; Sarah Mansour; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

6.  The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii.

Authors:  Xiaorong Feng; Karthik Sambanthamoorthy; Thomas Palys; Chrysanthi Paranavitana
Journal:  Peptides       Date:  2013-09-23       Impact factor: 3.750

7.  Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.

Authors:  Sibel Dosler; Elif Karaaslan; A Alev Gerceker
Journal:  J Chemother       Date:  2016-04       Impact factor: 1.714

8.  Prevalence of ESBL and MBL encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units (ICU).

Authors:  Marzieh Safari; Amir Sasan Mozaffari Nejad; Abas Bahador; Rasool Jafari; Mohammad Yousef Alikhani
Journal:  Saudi J Biol Sci       Date:  2015-01-17       Impact factor: 4.219

Review 9.  Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A Review.

Authors:  Jennifer N Lashinsky; Oryan Henig; Jason M Pogue; Keith S Kaye
Journal:  Infect Dis Ther       Date:  2017-03-29

10.  Enzymes Enhance Biofilm Removal Efficiency of Cleaners.

Authors:  Philipp Stiefel; Stefan Mauerhofer; Jana Schneider; Katharina Maniura-Weber; Urs Rosenberg; Qun Ren
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

View more
  17 in total

1.  Antibiofilm peptides as a promising strategy: comparative research.

Authors:  Jing Li; Dongru Chen; Huancai Lin
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-21       Impact factor: 4.813

Review 2.  Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat.

Authors:  William Gustavo Lima; Mara Cristina Alves; Waleska Stephanie Cruz; Magna Cristina Paiva
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-09       Impact factor: 3.267

Review 3.  Applications and evolution of melittin, the quintessential membrane active peptide.

Authors:  Shantanu Guha; Ryan P Ferrie; Jenisha Ghimire; Cristina R Ventura; Eric Wu; Leisheng Sun; Sarah Y Kim; Gregory R Wiedman; Kalina Hristova; Wimley C Wimley
Journal:  Biochem Pharmacol       Date:  2021-09-17       Impact factor: 6.100

4.  Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis.

Authors:  Rasoul Mirzaei; Mohammad Yousef Alikhani; Carla Renata Arciola; Iraj Sedighi; GholamReza Irajian; Elaheh Jamasbi; Rasoul Yousefimashouf; Kamran Pooshang Bagheri
Journal:  Front Microbiol       Date:  2022-06-23       Impact factor: 6.064

5.  Prevalence and antimicrobial resistance of shiga toxin-producing Escherichia coli and enteropathogenic Escherichia coli isolated from patients with acute diarrhea.

Authors:  Saeid Bouzari; Elham Farhang; Seyed Mostafa Hosseini; Mohammad Yousef Alikhani
Journal:  Iran J Microbiol       Date:  2018-06

6.  Hydrogels Embedded With Melittin and Tobramycin Are Effective Against Pseudomonas aeruginosa Biofilms in an Animal Wound Model.

Authors:  Michael M Maiden; Mitchell P Zachos; Christopher M Waters
Journal:  Front Microbiol       Date:  2019-06-20       Impact factor: 6.064

Review 7.  Promising Antimicrobial Properties of Bioactive Compounds from Different Honeybee Products.

Authors:  Magdalena Ratajczak; Dorota Kaminska; Eliza Matuszewska; Elżbieta Hołderna-Kedzia; Jarosław Rogacki; Jan Matysiak
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

Review 8.  Inhibition of Virulence Factors and Biofilm Formation of Acinetobacter Baumannii by Naturally-derived and Synthetic Drugs.

Authors:  Nilushi Indika Bamunuarachchi; Fazlurrahman Khan; Young-Mog Kim
Journal:  Curr Drug Targets       Date:  2021       Impact factor: 2.937

9.  Molecular typing of multi-drug resistant Acinetobacter baumannii isolates from clinical and environmental specimens in three Iranian hospitals by pulsed field gel electrophoresis.

Authors:  Ali Mohammadi Bardbari; Parviz Mohajeri; Mohammad Reza Arabestani; Manoochehr Karami; Fariba Keramat; Saba Asadollahi; Amir Khodavirdipour; Mohammad Yousef Alikhani
Journal:  BMC Microbiol       Date:  2020-04-25       Impact factor: 3.605

10.  Pan-Drug Resistant Acinetobacter baumannii, but Not Other Strains, Are Resistant to the Bee Venom Peptide Mellitin.

Authors:  Rangel Karyne; Guilherme Curty Lechuga; André Luis Almeida Souza; João Pedro Rangel da Silva Carvalho; Maria Helena Simões Villas Bôas; Salvatore Giovanni De Simone
Journal:  Antibiotics (Basel)       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.